JANX vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

JANX

41.5
AI Score
VS
ZBIO Wins

ZBIO

51.0
AI Score

Investment Advisor Scores

JANX

42score
Recommendation
HOLD

ZBIO

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric JANX ZBIO Winner
Net Income -67.90M -377.74M JANX
Operating Income -97.16M -383.06M JANX
ROE -7.4% -156.0% JANX
ROA -6.9% -98.5% JANX
Total Assets 983.65M 383.64M JANX
Cash 41.82M 110.64M ZBIO
Current Ratio 17.69 5.61 JANX
Free Cash Flow -25.51M -172.35M JANX

Relative Price Performance (Last 90 Days)

JANX 1M: -32.9% · 3M: -28.7% ZBIO 1M: +11.2% · 3M: -6.3%

Current Technical Phase

JANX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.8%), weak momentum, RSI 29

RSI (14): 29.3 · Price: $11.50

ZBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.2 · Price: $27.64

Fundamentals Snapshot

Metric JANX ZBIO
Market Cap — —
Forward P/E -4.5 -5.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.1% -1.0%
Gross Margin -4.1% -20.6%
Operating Margin -6.0% -27.5%
EPS -1.59 -10.11
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZBIO is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.